米国の防腐剤・消毒剤市場規模、シェア、動向分析レポート：タイプ別、製品タイプ別、最終用途別、販売チャネル別、セグメント別予測、2025年～2030年

米国の防腐剤・消毒剤市場のサマリー

米国の防腐剤・消毒剤市場規模は2024年に94億1,000万米ドルとなり、2025年から2030年にかけてCAGR 10.8%で成長し、2030年には170億7,000万米ドルに達すると予測されます。インフルエンザ、A型肝炎、腸チフス、コレラ、デング熱などの疾病の流行増加は、防腐剤・消毒剤市場の成長を促す主な要因の1つです。

米国疾病予防管理センター（CDC）によると、2023～2024年のインフルエンザシーズンは、米国で推定4,000万人の疾病、47万人の入院、2万8,000人の死亡につながりました。ヘルスケアと地域社会の両方の環境における効果的な消毒の必要性が、米国の防腐剤・消毒剤産業を牽引しています。米国では外科手術や入院患者の医療処置が増加しており、防腐剤と消毒剤の需要を大幅に押し上げています。各手技では、ヘルスケア関連感染のリスクを最小限に抑えるため、厳格な滅菌プロトコルと無菌的な実践が求められます。慢性疾患の蔓延と人口の高齢化は、入院率の上昇に寄与しています。このような持続的な患者数の増加は、表面汚染リスクを増大させ、ヘルスケア施設全体で一貫した効果的な消毒方法の必要性を強めています。

米国環境保護庁（EPA）や食品医薬品局（FDA）などの規制機関は、米国業界の形成に重要な役割を果たしています。これらの機関は、特にヘルスケア環境において、製品の有効性、安全性、表示に関する厳格な基準を実施しています。EPAは、病院用消毒剤に対し、幅広い病原菌に対する有効性を証明するための厳格な試験を義務付けています。一方、FDAは患者に使用される消毒薬の安全性と処方を監督しています。このような規制環境は、メーカーの技術革新を促し、ヘルスケアプロバイダーが準拠した高品質の消毒ソリューションを採用する原動力となっています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の防腐剤・消毒剤市場の変数、動向、範囲

• 市場系統の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 業界の課題
• 業界分析ツール
  • PORTERの分析
  • PESTEL分析

第4章 米国の防腐剤・消毒剤市場：タイプ推定・動向分析

• 米国の防腐剤・消毒剤市場（タイプ別）：主なポイント
• タイプ変動分析と市場シェア、2024年と2030年
• タイプ別、2018年～2030年
  • 第四級アンモニウム化合物
  • 塩素化合物
  • アルコールおよびアルデヒド製品
  • 酵素
  • その他

第5章 米国の防腐剤・消毒剤市場：製品タイプの推定・動向分析

• 米国の防腐剤・消毒剤市場（製品タイプ別）：主なポイント
• 製品タイプの変動分析と市場シェア、2024年と2030年
• 製品タイプ別、2018年-2030年
  • 酵素クリーナー
  • 医療機器消毒剤
  • 表面消毒剤

第6章 米国の防腐剤・消毒剤市場：最終用途の推定・動向分析

• 米国の防腐剤・消毒剤市場（最終用途別）：主なポイント
• 最終用途変動分析と市場シェア、2024年および2030年
• 最終用途別、2018年～2030年
  • 病院
  • クリニック
  • その他

第7章 米国の防腐剤・消毒剤市場：販売チャネルの推定・動向分析

• 米国の防腐剤・消毒剤市場（販売チャネル別）：主なポイント
• 販売チャネル変動分析と市場シェア、2024年および2030年
• 販売チャネル別、2018年～2030年
  • B2B
  • 日用消費財

第8章 競合情勢

• 企業分類
• 企業の市場ポジショニング
• 企業ヒートマップ分析
• 企業プロファイル/上場企業
  • 3M
  • Reckitt Benckiser
  • Steris Plc
  • Kimberly-Clark Corporation
  • Bio-Cide International, Inc.
  • Cardinal Health
  • BD
  • Johnson &Johnson

List of Tables

• Table 1. List of abbreviations
• Table 2. U.S. antiseptic and disinfectant market: key market driver analysis
• Table 3. U.S. antiseptic and disinfectant market: Key market restraint analysis
• Table 4. U.S. antiseptic and disinfectant market estimates and forecast, by type (USD Million)
• Table 5. U.S. antiseptic and disinfectant market estimates and forecast, by product type (USD Million)
• Table 6. U.S. antiseptic and disinfectant market estimates and forecast, by end use (USD Million)
• Table 7. U.S. antiseptic and disinfectant market estimates and forecast, by sales channel (USD Million)
• Table 8. Recent developments and impact analysis by key market participants
• Table 9. Company heat map analysis, 2024
• Table 10. Companies implementing key strategies

List of Figures

• Fig. 1 U.S. Antiseptic and disinfectant market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing and forecasting
• Fig. 7 Parent market analysis
• Fig. 8 Market formulation and validation
• Fig. 9 U.S. Antiseptic and disinfectant market snapshot
• Fig. 10 U.S. Antiseptic and disinfectant market segment snapshot
• Fig. 11 U.S. Antiseptic and disinfectant market competitive landscape snapshot
• Fig. 12 Market research process
• Fig. 13 Market driver relevance analysis (Current and future impact)
• Fig. 14 Market restraint relevance analysis (Current and future impact)
• Fig. 15 U.S. Antiseptic and disinfectant market: Type outlook key takeaways (USD Million)
• Fig. 16 U.S. Antiseptic and disinfectant market: Type movement analysis, 2024 & 2030 (USD Million)
• Fig. 17 Quaternary ammonium compounds market estimates & forecasts, 2018 - 2030 (USD Million)
• Fig. 18 Alcohols & aldehyde products market estimates & forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Enzyme market estimates & forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Others market estimates & forecasts, 2018 - 2030 (USD Million)
• Fig. 21 U.S. Antiseptic and disinfectant market: Product Type outlook key takeaways (USD Million)
• Fig. 22 U.S. Antiseptic and disinfectant market: Product Type movement analysis, 2024 & 2030 (USD Million)
• Fig. 23 Enzymatic cleaners market estimates & forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Medical device disinfectants market estimates & forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Surface disinfectants market estimates & forecasts, 2018 - 2030 (USD Million)
• Fig. 26 U.S. antiseptic and disinfectant market: End Use outlook key takeaways (USD Million)
• Fig. 27 U.S. antiseptic and disinfectant market: End Use movement analysis, 2024 & 2030 (USD Million)
• Fig. 28 Hospitals market estimates & forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Clinics market estimates & forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Others market estimates & forecasts, 2018 - 2030 (USD Million)
• Fig. 31 U.S. antiseptic and disinfectant market: Sales Channel outlook key takeaways (USD Million)
• Fig. 32 U.S. antiseptic and disinfectant market: Sales Channel movement analysis, 2024 & 2030 (USD Million)
• Fig. 33 B2B market estimates & forecasts, 2018 - 2030 (USD Million)
• Fig. 34 FMCG market estimates & forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Strategy framework
• Fig. 36 Company categorization

U.S. Antiseptic And Disinfectant Market Summary

The U.S. antiseptic and disinfectant market size was valued at USD 9.41 billion in 2024 and is projected to reach USD 17.07 billion by 2030, growing at a CAGR of 10.8% from 2025 to 2030. An increase in the prevalence of diseases, such as influenza, hepatitis A, typhoid, cholera, and dengue, is one of the major factors driving the antiseptic & disinfectant market growth.

According to the Centers for Disease Control and Prevention (CDC), the 2023 - 2024 flu season led to an estimated 40 million illnesses, 470,000 hospitalizations, and 28,000 deaths in the U.S. The need for effective disinfection in both healthcare and community settings drives the U.S. antiseptic and disinfectant industry. The increasing number of surgical and inpatient medical procedures in the U.S. significantly drives demand for antiseptics and disinfectants. Each procedure requires stringent sterilization protocols and aseptic practices to minimize the risk of healthcare-associated infections. The growing prevalence of chronic diseases and an aging population are contributing to higher hospitalization rates. This sustained patient volume increases surface contamination risks, reinforcing the need for consistent and effective disinfection practices across healthcare facilities.

Regulatory organizations such as the U.S. Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) play a vital role in shaping the U.S. industry. These agencies enforce strict standards for product efficacy, safety, and labeling, particularly in healthcare environments. The EPA mandates that hospital-grade disinfectants undergo rigorous testing to prove effectiveness against a broad range of pathogens. Meanwhile, the FDA oversees the safety and formulation of antiseptics used on patients. This regulatory environment encourages manufacturers to innovate and drives healthcare providers to adopt compliant, high-quality disinfection solutions.

U.S. Antiseptic And Disinfectant Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. antiseptic and disinfectant market report based on type, product type, end use, and sales channel:

• Type Outlook (Revenue, USD Million, 2018 - 2030)
• Quaternary Ammonium Compounds
• Chlorine Compounds
• Alcohols & Aldehyde Products
• Enzyme
• Others
• Product Type Outlook (Revenue, USD Million, 2018 - 2030)
• Enzymatic Cleaners
• Medical Device Disinfectants
• Surface Disinfectants
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Clinics
• Other
• Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)
• B2B
• FMCG

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources and Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation and Data Visualization
• 1.6. Data Validation and Publishing

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Antiseptic And Disinfectant Market Variables, Trends and Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
  • 3.2.3. Industry Challenge
• 3.3. Industry Analysis Tools
  • 3.3.1. PORTER's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and social landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Antiseptic And Disinfectant Market: Type Estimates and Trend Analysis

• 4.1. U.S. Antiseptic And Disinfectant Market, By Type: Key Takeaways
• 4.2. Type Movement Analysis and Market Share, 2024 and 2030
• 4.3. Market Estimates and Forecasts, By Type, 2018 - 2030 (USD Million)
  • 4.3.1. Quaternary Ammonium Compounds
    • 4.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.2. Chlorine Compounds
    • 4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.3. Alcohols & Aldehyde Products
    • 4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.4. Enzyme
    • 4.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3.5. Other
    • 4.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Antiseptic And Disinfectant Market: Product Type Estimates and Trend Analysis

• 5.1. U.S. Antiseptic And Disinfectant Market, By Product Type: Key Takeaways
• 5.2. Product Type Movement Analysis and Market Share, 2024 and 2030
• 5.3. Market Estimates and Forecasts, By Product Type, 2018 - 2030 (USD Million)
  • 5.3.1. Enzymatic Cleaners
    • 5.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.2. Medical Device Disinfectants
    • 5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.3. Surface Disinfectants
    • 5.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Antiseptic And Disinfectant Market: End Use Estimates and Trend Analysis

• 6.1. U.S. Antiseptic And Disinfectant Market, By End Use: Key Takeaways
• 6.2. End Use Movement Analysis and Market Share, 2024 and 2030
• 6.3. Market Estimates and Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 6.3.1. Hospitals
    • 6.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. Clinics
    • 6.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Other
    • 6.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Antiseptic And Disinfectant Market: Sales Channel Estimates and Trend Analysis

• 7.1. U.S. Antiseptic And Disinfectant Market, By Sales Channel: Key Takeaways
• 7.2. Sales Channel Movement Analysis and Market Share, 2024 and 2030
• 7.3. Market Estimates and Forecasts, By Sales Channel, 2018 - 2030 (USD Million)
  • 7.3.1. B2B
    • 7.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. FMCG
    • 7.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Company Market Positioning
• 8.3. Company Heat Map Analysis
• 8.4. Company Profiles/Listing
  • 8.4.1. 3M
    • 8.4.1.1. Company Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Portfolio
    • 8.4.1.4. Recent Developments/ Strategic Initiatives
  • 8.4.2. Reckitt Benckiser
    • 8.4.2.1. Company Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Portfolio
    • 8.4.2.4. Recent Developments/ Strategic Initiatives
  • 8.4.3. Steris Plc
    • 8.4.3.1. Company Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Portfolio
    • 8.4.3.4. Recent Developments/ Strategic Initiatives
  • 8.4.4. Kimberly-Clark Corporation
    • 8.4.4.1. Company Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Portfolio
    • 8.4.4.4. Recent Developments/ Strategic Initiatives
  • 8.4.5. Bio-Cide International, Inc.
    • 8.4.5.1. Company Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Portfolio
    • 8.4.5.4. Recent Developments/ Strategic Initiatives
  • 8.4.6. Cardinal Health
    • 8.4.6.1. Company Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Portfolio
    • 8.4.6.4. Recent Developments/ Strategic Initiatives
  • 8.4.7. BD
    • 8.4.7.1. Company Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Portfolio
    • 8.4.7.4. Recent Developments/ Strategic Initiatives
  • 8.4.8. Johnson & Johnson
    • 8.4.8.1. Company Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Portfolio
    • 8.4.8.4. Recent Developments/ Strategic Initiatives